PULMONARY DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Drug Class
• Market Snapshot, By Application
• Market Snapshot, By Distribution Channel
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Regulatory Scenario
• Pipeline Analysis
• Promotional Activities and Campaigns
• Supply Chain Analysis
• PEST Analysis
• Epidemiology

4. Global Pulmonary Drugs Market, By Drug Class, 2026 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Inhaled Corticosteroids
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Long Acting Beta-2 Agonists
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Antihistamines
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Vasodilators
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Short Acting Beta-2 Agonists
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Others
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends

5. Global Pulmonary Drugs Market, By Application, 2026 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Asthma & COPD
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Allergic Rhinitis
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Pulmonary Arterial Hypertension
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Cystic Fibrosis
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Others
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends

6. Global Pulmonary Drugs Market, By Distribution Channel, 2026 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Hospital Pharmacies
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Retail Pharmacies
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• E-Commerce
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends

7. Global Pulmonary Drugs Market, By Region, 2026 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Drug Class, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Drug Class, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Drug Class, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• UK
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Drug Class, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Drug Class, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Drug Class, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
• Sanofi SA
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Meda Pharmaceuticals
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Circassia Pharmaceuticals Plc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• AstraZeneca Plc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• GlaxoSmithKline Plc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Mallinckrodt Pharmaceuticals Plc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Cheisi Farmaceutici S.p.A
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Zambon Company S.p.A
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Alaxia SAS
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Merck Sharp & Dohme Limited
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
• Analyst Views

9. Section

• References
• Research Methodology
• About Us and Sales Contact